A ketogenic diet may improve symptoms of depression, according to a new review and meta-analysis published in JAMA Psychiatry ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

The ketogenic diet significantly improves symptoms in epilepsy, schizophrenia, as well as in alcohol use disorder, opioid use ...

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the ...

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to James ...

Analysis links a PROK2 mutation to Kallmann syndrome, bolstering wartime claims that the dictator had only one testicle.

Britain’s grey skies can darken anyone’s mood, but for those who suffer with seasonal affective disorder (SAD), winter can be ...

New findings reported in JAMA Network Open from a longitudinal cohort study utilizing electronic health records (EHRs) show that individuals with a prior serious mental illness (SMI), including ...

Recent DNA analysis of Adolf Hitler's genetic material suggests he had Kallmann syndrome, a rare genetic disorder affecting ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

LB Pharmaceuticals, Inc ('LB Pharmaceuticals” or the 'Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company ...